Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of 1% MIM-D3 and 5% MIM-D3
to placebo for the treatment of the signs and symptoms of dry eye.